For example, miR‐149‐3p reduces the viability and proliferative capacity of oral squamous cell carcinoma by decreasing AKT2 expression and increasing its sensitivity to the chemotherapeutic agent 5‐fluorouracil.25 Here, AKT2 is linked to oral cavity squamous cell carcinoma.